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Abstract
Background: The aim of the study was to investigate odor identification performance in patients one year after
hospital admittance due to stroke. Predictors for olfactory dysfunction were investigated as well as self-reported
olfactory function and pleasantness of olfactory items.
Methods: A 1-year prospective study was performed. Stroke location, classification and comorbidities were
registered at hospital admission. One year after admission, olfactory function was assessed using standardized
olfactory methods (screening for loss of detection sensitivity and an odor identification test). A group of matched
controls was derived from a population-based study to compare odor identification performance between groups.
Patients were asked for their personal judgment regarding their olfactory function and pleasantness of odorous
items. In addition, global cognitive function and symptoms of depression were assessed.
Results: A total of 78 patients were enrolled (46 males, 32 females; mean age 68 years) of which 28.2 % exhibited
reduced olfactory function (hyposmia) and 15.4 % exhibited loss of olfactory function (10.3 % functional anosmia, 5.1 %
complete anosmia). Patients showed significantly lower olfactory performance compared to age- and sex-mated
matched controls. Predictors of impaired olfactory function were age and NIHSS score. Self-reports indicated no
significant differences between patients with normal olfactory function and those with reduced function. Yet, patients
having an olfactory dysfunction rated odorous items as significantly less pleasant compared to patients without
dysfunction.
Conclusions: Olfactory dysfunction seems to occur frequently after stoke even one year after initial admission. The
deficits seem to relate to hyposmia and functional anosmia, and less to a complete loss of smell sensitivity.
Keywords: Olfaction, Stroke, Odor identification
Background
The sense of smell provides us with crucial information
about the environment and contributes to important
aspects of life. Lately, interest in olfactory dysfunction
has increased due to findings indicating that olfactory
dysfunction is associated with increased risk of mortality
[1], degenerative disease such as Alzheimer’s disease and
Parkinson’s disease [2, 3], as well as due to the general
appreciation of olfaction being important for quality of
life. Olfactory dysfunction can result in altered food
enjoyment, poor appetite, difficulties preparing food, in-
ability to detect hazardous conditions (e.g., gas, smoke
and spoiled food), lack of understanding of others and
social isolation, depression and mood changes [4, 5].
Although a rather large number of medical conditions
are well documented regarding their impact on olfaction
[6], only a few studies have investigated olfactory func-
tion in stroke patients. Population-based studies that
have estimated the risk of olfactory dysfunction in the
aging segment of the population provide ambiguous re-
sults regarding stroke. Whereas both Murphy et al. [7]
and Karpa et al. [8] showed that stroke was a risk factor
for olfactory dysfunction, Schubert et al. [9] and Landis
et al. [10] could not support these findings. The
remaining available literature on stroke and olfaction
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includes case studies. For example, these studies show
that stroke patients do not have a complete loss of olfac-
tory function, but rather experience unpleasant sensa-
tion of odors [11–16]. Cecchini et al. [17] reported
slightly reduced olfactory function in two out of the
three patients they investigated.
One aim of this study was to investigate the ability to
identify odors in chronic stroke patients. This was stud-
ied by comparing patients’ performance on a common
clinical measure of olfactory function [18–20] with an
age- and sex-matched sample of referents from a
population-based study. The stroke patients and refer-
ents were compared with respect to performance score
on odor identification as well as distribution of olfactory
diagnosis. This included normosmia (normal olfaction),
hyposmia (reduced olfactory function) and functional
anosmia (significantly impaired olfaction, including both
total loss and minimal residual perception) [21]. A second
aim was to investigate predictors of odor identification per-
formance. This comprised functional effects of stroke at the
time of admission and during follow-up. A third aim was to
compare patients being classified as normosmic versus
hyposmic/anosmic with respect to self-reported olfactory
functioning and odor pleasantness ratings.
Methods
Stroke patients
The sample of stroke patients consisted of patients
admitted to the Stroke Unit at the Department of
Neurology, Haukeland University Hospital (HUH), Bergen,
Norway in 2009–2012. These patients were part of a larger
project on rehabilitation. Inclusion criteria comprised pa-
tients living at home at the time of admission, a verification
of stroke by magnet resonance imaging (MRI) or computer
tomography (CT), an NIHSS score between 2 and 26, and
a score ≥2 on the modified Rankin Scale. Patients had to
be awake and able to consent. If the patient was not cap-
able of giving his or her consent it was given by a next-of-
kin. There was no age-limit. Exclusion criteria were serious
psychiatric disorder, alcohol or substance abuse, serious
conditions interfering with the subsequent rehabilitation
process, and insufficient knowledge of the Norwegian
language (pre-stroke). At initial hospital admission,
the patients underwent a comprehensive neurological
examination to establish a diagnosis of stroke, clinical
syndrome, pathological, and etiological subtype of stroke
and neurological deficits, as assessed by the NIHSS [22],
and MRI or CT. One year after initial admission, the pa-
tients were invited to return for a comprehensive neuro-
psychological assessment including a battery of cognitive
tests, questionnaires, and assessment of olfactory function.
All patients gave written informed consent. In total, 78 pa-
tients (n = 73 with cerebral infarction, n = 5 with cerebral
hemorrhage) were initially screened for anosmia regarding
odor detection sensitivity with a simplified version (for de-
tails, see [23]) of the Connecticut Chemosensory Clinical
Research Center Threshold Test [24]. Four patients were
evaluated as anosmic, making the subsequent test of odor
identification meaningless. The remaining 74 patients
underwent assessment with the odor identification test.
Patient characteristics are shown in Table 1.
On admission, clinical stroke subtype was classified
according to the Oxfordshire Community Stroke Pro-
ject (OCSP) [25]. This included partial anterior circu-
lation infarct (PACI, n = 37), posterior circulation
infarct (POCI, n = 12), total anterior circulation infarct
(TACI, n = 4), and lacunar circulation infarct (LACI,
n = 20). According to the protocol at the HUH, the
following risk factors were registered on admittance:
hypertension (n = 37), smoking at admission (n = 18),
diabetes mellitus (n = 8), myocardial infarction (n = 9),
angina pectoris (n = 7), and peripheral artery disease
(n = 3) (Table 2).
Hypertension was defined as prior use of antihyperten-
sive medication. Diabetes mellitus was considered
present if the patient was on glucose-lowering diet or
medication. Angina pectoris, myocardial infarction and
peripheral artery disease were considered present if diag-
nosed by a physician any time before stroke onset. Atrial
fibrillation required ECG confirmation any time prior to
stroke onset or during the hospital stay. A history of
prior stroke was registered. In 17.9 % (n = 14) of the
sample, the present stroke was a recurrent vascular
event; 11.5 % were registered with an earlier stroke, 6 %
with a transient ischemic attack (TIA). The etiology of
ischemic stroke was determined by TOAST (the Trial of
Org 10172 in Acute Stroke Treatment classification), in-
cluding large artery atherosclerosis (n = 11), cardioembo-
lism (n = 21), small vessel occlusion (n = 14), other
etiology (n = 1), and undetermined etiology (n = 26)
(Table 2). NIHSS scores ranged from 0 to 18 (Median 4),
indicating that the patients, on average, were slightly to
moderately affected by the stroke. By the time of admis-
sion, all patients were living at home independently, and
one received help from the district nursing office.
A population-based sample of referents (n = 148) were
semi-randomly selected from the Skövde Population-
Based Study [26] for comparison with the sample of
stroke patients who underwent assessment with the
Scandinavian Odor Identification Test (SOIT) [27]. Each
stroke patient was matched subject-by-subject for age
(±1 year) and sex to two referents. Both samples had a
mean age of 67.0 (SD = 12.5) years. The patients con-
sisted of 44 men and 30 women, and the referents of 88
men and 60 women.
The main project was approved by the Regional Com-
mittee for Research Ethics of Western Norway. The
studies were performed according to the Declaration of
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Helsinki on guidelines for biomedical research involving
human subjects (World Medical Association, 2013).
Scandinavian odor identification test
The SOIT was used to objectively assess olfactory func-
tion; a test which has adequate psychometric properties
[27] and is valid for use in Norwegian samples [28]. The
test includes the sixteen odorants pine needle, pepper-
mint, juniper berry, violet, anise, clove, vanilla, almond
(bitter), orange, cinnamon, lemon, lilac, vinegar, tar, am-
monia, and apple. Ammonia (1.0 M), tar, and vinegar
were natural products while the other odorants were
natural oils (Stockholm Ether & Essence Manufactory,
Stockholm, Sweden). The odorant was injected into a
tampon filled to saturation and placed into an opaque,
80 ml glass jar, sealed with a teflon lock. The stimuli
were presented birhinally 1–5 cm under the participants’
nose. A card with four written response alternatives was
placed in front of the participant with the instruction
to choose the item that most appropriately identified
the odor, with a forced-choice procedure. To avoid
adaptation, each stimulus was presented no longer
than 3–4 s. No time restrictions were given for the
participants to make their choice. The inter-stimulus
interval was about 20 s to avoid significant effects of
adaptation [29]. Testing was conducted in a well-
ventilated room without background odor. For ana-
lyses, the number of correctly identified odors was
used. Based on this number, the participants were
categorized as either normosmic, hyposmic, or func-
tionally anosmic according to the age- and sex-
dependent normative data for the SOIT [27].
Table 1 Baseline characteristics of all patients according to the protocol at admission and olfactory status at follow-up
Total n Normosmic Hyposmic Anosmic
Total, % 78 44 (56.4 %) 22 (28.2 %) 12 (15.4 %)
Male 46 27 (58.7 %) 11 (23.9 %) 8 (17.4 %)
Stroke type, ischemic 73 43 (58.9 %) 19 (26.0 %) 11 (15.1 %)
NIHSS score on admission* 3.9 (3.8) 7.3 (4.3) 6.0 (5.0)
Diabetes 9 4 (44.4 %) 2 (22.2 %) 2 (22.2 %)
Myocardial infarction 9 4 (44.4 %) 5 (55.6 %) –
Angina pectoris 9 4 (44.4 %) 1 (11.1 %) 4 (44.4 %)
Peripheral artery disease 3 1 (33.3 %) 2 (66.7 %) –
Leukoaraiosis 22 13 (59.1 %) 7 (31.8 %) 2 (9.1 %)
Hypertension 39 21 (53.8 %) 10 (25.6 %) 8 (20.5 %)
Earlier stroke 9 6 (66.7 %) 2 (22.2 %) 1 (11.1 %)
Earlier transient ischemic attack (TIA) 5 2 (40 %) 2 (40 %) 1 (20 %)
Smoking on admission 18 12 (66.7 %) 5 (27.8 %) 1 (5.6 %)
1 year follow up
Age ≥60 years at follow-up 57 33 (57.9 %) 15 (26.3 %) 9 (15.8 %)
MMSE* 28.2 (2.1) 27.7 (2.5) 27.8 (2.5)
HADS D* 2.7 (1.9) 2.9 (2.6) 3.4 (2.5)
Smoking at follow up 9 6 (66.7 %) 3 (33.3 %) –
Problems breathing through nose 2 1 (50 %) 1 (50 %) –
Frequent sinusitis 2 1 (50 %) 1 (50 %) –
*M(SD)
Table 2 Distribution of stroke causes (TOAST criteria) and stroke
location (Oxfordshire Community Stroke Project Criteria (OCPS)
Criteria Total n Normosmic Hyposmic Anosmic
TOAST criteria
Large artery atherosclerosis 11 7 2 2
Cardioembolism 21 14 4 3
Small vessel occlusion 14 7 4 3
Stroke of other
determined etiology
1 1 0 0
Stroke of undetermined
etiology
26 11 11 4
OCPS criteria
PACI 37 18 11 8
POCI 12 9 2 1
TACI 4 2 1 1
LACI 20 11 7 2
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Self-reported olfactory function and pleasantness ratings
At follow-up, the participants initially underwent a short
questionnaire regarding factors with potential effect on ol-
factory functioning (current and past smoking, problems
breathing through nose, frequent sinusitis). This was
followed by a question regarding self-reported olfactory
functioning “How would you estimate your sense of smell
on a scale from 1–5 (1 = quite poor, 5 = excellent)?” After
presenting each odor item of the SOIT, the participant
was asked to rate the pleasantness of that odor on a scale
ranging from 1 (not pleasant) to 5 (very pleasant). Ratings
were averaged over all 16 items for analyses.
Cognitive function and depression
Global cognitive function was assessed with the Mini-
Mental State Examination (MMSE), which is a brief 30-
point questionnaire sampling various cognitive functions
such as arithmetic, episodic memory, orientation and
language skills [30]. The scale ranges from 0 to 30 (high
score representing high level of cognitive function). The
depression subscale of the Hospital Anxiety and Depres-
sion Scale (HADS) [31] was used to quantify degree of
depression. The subscale has seven items (e.g., “I have
lost interest in my appearance”), asking the respondent
to answer the questions according to the feelings of the
past week. The scale ranges from 0 to 21 (high score
representing high anxiety/depression level).
Statistical analyses
Mean scores on the SOIT were compared between the
group of stroke patients and referents with paired t-tests
averaging the SOIT performance scores from the two
referents per patient. The distributions across olfactory
diagnoses were compared between groups using the
McNemar Bowker Test, after first averaging the SOIT
performance scores from the two referents and subse-
quently categorizing them based on the normative data
[27]. Pearson correlation coefficients were computed be-
tween, on the one hand, SOIT score and on the other
hand, age, the score of the NIHSS, MMSE and HADS
depression scale. T-tests were used to analyze sex-
differences on SOIT score in stroke patients. Statistical
predictors of SOIT score were tested in multiple linear
regression analyses including age, NIHSS score, score on
the depression subscale of the HADS, and MMSE score.
Variables in this analysis were selected when they
reached the moderately strict α-level of 0.10, for the
remaining analyses, the α-level was set at 0.05. The ana-
lyses were performed using SPSS software version 21.
Results
Performance on odor identification
Mean (SD) score on the SOIT was 11.0 (2.6) for the
stroke patients, and 12.6 (2.2) for the referent pairs,
which differed significantly (t (72) = 4.67, p <0.001).
Based on these scores and normative data [27], 40.5 %
(n = 30) of the stroke patients and 23.0 % of the referent
pairs had an olfactory dysfunction (hyposmia or func-
tional anosmia). More specifically, 59.5 % (n = 44) of the
stroke patients were normosmic, 29.7 % (n = 22) were
hyposmic, and 10.8 % (n = 8) were functionally anosmic.
Corresponding percentages for the referent pairs were
83.7 % (n = 62), 14.9 % (n = 11) and 1.4 % (n = 1), re-
spectively. The distributions across olfactory diagnoses
differed significantly between the two groups (McNemar
Bowker df (3) = 13.62, p <0.004). Thus, compared to the
referents, the stroke patients had significantly lower
SOIT scores, and consisted to a significantly larger ex-
tent of persons with hyposmia and functional anosmia.
Since the group of stroke patients included a number
of patients for whom an earlier vascular event (stroke or
TIA) had been registered, analyses were re-run, exclud-
ing those 12 patients and their respective 24 matched
controls. The differences regarding SOIT score and dis-
tribution across olfactory diagnoses remained significant
(t (60) = 4.13, p <0.001 and McNemar Bowker df (3) =
10.02, p <0.02, respectively.
Predictors of olfactory dysfunction
Pearson correlation analyses indicated that age (r = −0.28,
p <0.02) and NIHSS score (r = −0.35, p <0.02) correlated
significantly with SOIT score, whereas MMSE score of
global cognitive function (r = 0.2, p <0.09) and score on
the HADS depression scale (r = 0.23, p <0.06) showed only
strong tendencies of such correlations. No sex differences
regarding SOIT scores were found (t (72) = 0.87, p >0.38).
Results from multiple regression analyses with SOIT as
dependent variable are shown in Table 3. Age and NIHSS
were found to be significant predictors, whereas neither
MMSE score nor HADS depression score were, when
controlled for age and NIHSS score.
Self-reported olfactory functioning and pleasantness
judgments
Comparison of means for self-reported olfactory function
in normosmic (M= 3.72 (SD 0.97) vs. hyposmic/anosmic
stroke patients (M = 3.57 (SD 0.99) revealed no significant
difference regarding self-reported olfactory function
(t (57) = 0.521, p = 0.604). Average mean (SD) ratings
for odor pleasantness was 2.94 (0.45) for the nor-
mosmic stroke patients, and 2.52 (0.54) for the
hyposmic/anosmic patients. This difference was sig-
nificant (t (72) = 3.12, p = 0.003).
Discussion
In summary, the findings demonstrate olfactory dysfunc-
tion in a significantly larger proportion of chronic stroke
patients compared to a group of matched controls.
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Moreover, we found that age and NIHSS score (on admis-
sion) were significant predictors for olfactory dysfunction.
Self-reported olfactory function did not differ between
stroke patients with and without olfactory dysfunction. Yet,
average pleasantness ratings differed significantly, indicating
that patients with reduced olfactory function, on average,
perceived olfactory items as less pleasant compared to
patients with normal olfactory status.
The results indicating that olfactory dysfunction occurs
as frequent as in 43 % in chronic stroke patients even one
year after initial admission are notable and new. It has to
be acknowledged that four patients in our study com-
pletely lacked ability to perceive odor (due to the initial
screening procedure). This number is in accordance with
findings from population-based studies, reporting ap-
proximately 5 % to be unable to smell [21, 26]. Addition-
ally, another 10.3 % of the patients showed functional
anosmia, based on results from the odor identification
test. It should be emphasized that the high correlation be-
tween odor detection sensitivity and identification ability
validates the use of identification tasks to assess hyposmia
and anosmia [32]. Individuals with functional anosmia do
indeed also experience impact on quality of life [5]. Thus,
the frequent occurrence of olfactory dysfunction in pa-
tients stresses that clinicians should be aware of this issue
in clinical routines, though maybe not in the acute phase
as focus lies on other medical issues.
Our findings, indicating age to be a significant predictor
for olfactory performance, are in accordance with the
well-established literature [18, 28, 33]. In addition, NIHSS
score remained a significant predictor even when control-
ling for age. The current findings extend the existing stud-
ies addressing the long-term consequences of stroke. The,
NIHSS has been shown to be a predictor for stroke out-
come and there is evidence showing that it may be asso-
ciated with the development of vascular cognitive
impairment (VCI) and eventually a diagnosis of dementia
[34, 35]. Olfactory dysfunction is a well-established marker
for dementia [3, 36] and is even known to occur in indi-
viduals at risk for dementia who demonstrate mild cogni-
tive impairment [37, 38]. However, findings on VCI and
olfactory dysfunction are still scarce. It has been shown
that patients with vascular dementia perform below nor-
mative performance in olfactory tests [39]. Nonetheless,
when comparing patients with vascular dementia and
patients with AD, findings are mixed in that Gray et al.
[39] report a similar degree of olfactory impairment in
both patient groups, whereas Duff et al. [40] have shown
lower performance in AD patients. In our sample, none of
the patients had received a diagnosis of dementia at the
time of assessment, although we cannot rule out that
some patients may have been on a path towards decline.
Moreover, the results indicate only a tendency of an asso-
ciation between global cognitive function (MMSE) and
odor identification performance. Odor identification
draws on memory functions [41], but processing speed,
language proficiency and reasoning have also shown to be
involved [42–44]. Cognitive changes in VCI are variable
depending on the lesion location [35], plausible explana-
tions for finding a trend only may be that the sample was
too heterogeneous to detect possible associations. Add-
itional, screening instruments for dementia such as the
MMSE, which was primarily developed for assessing cog-
nitive deficits associated with AD, often do not detect
those subtle deficits as seen in VCI [35]. Yet, since up to
50 % of individuals with VCI develop dementia in a five-
year period [45], the current findings underline the urgent
need for more knowledge.
The finding indicating no differences for self-reported
olfactory functioning between normosmic patients and
those with an olfactory dysfunction are not surprising since
it has repeatedly been shown that self-reports are unreliable
predictors of olfactory status [28, 46, 47]. It has been
discussed that due to the subtle progression of decline a
certain threshold must be reached before loss becomes
noticeable [37]. The present finding of unawareness of
olfactory dysfunction in stroke patients underlines the need
for clinicians to objectively assess olfactory function in this
patient population.
It is notable that those patients with an olfactory dysfunc-
tion perceive the odors as less pleasant than normosmic
patients. This is in accordance with case studies which
repeatedly have reported qualitative smell and taste distur-
bances [11–14, 16]. These reports vary regarding the
Table 3 Results of multiple hierarchical regression analyses
Predictor B SE B Incr R2 Cum R2 β p 95% CI lower bound 95% CI upper bound
Age −0.058 0.023 0.081 0.081 −0.284 0.014 −0.105 −0.012
Age −0.051 0.023 0.081 0.081 −0.248 0.025 −0.095 −0.007
NIHSS −0.184 0.062 0.101 0.182 −0.321 0.004 −0.308 −0.061
Age −0.048 0.024 0.081 0.081 −0.235 0.048 −0.096 0.00
NIHSS −0.180 0.064 0.101 0.182 −0.313 0.006 −0.308 −0.053
MMSE 0.041 0.131 0.001 0.184 0.037 0.754 −0.220 0.302
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duration of the disturbances, varying between weeks and
years. Our results showing that dysfunction may occur
even a year after injury underline a prolonged course.
Additional, existing findings have commonly stressed
that the patients had not completely lost their ability
to smell, but that change in perceptual quality of the
odorous stimuli was a serious problem as it resulted
in changes in diet and eventually weight loss [11, 16].
Our results indicate a clear trend between symptoms
of depression and odor identification performance.
Signs of depression are a known consequence in pa-
tients with smell loss [48]. Croy et al. [5] suggested
two potential links between depression and olfactory
disorders: One arising through reduced quality of life
in functions depending on olfaction (eating, social
communication, environmental hazards etc.) and thus
indirectly leading to depression, and another directly
related to brain function in that olfactory input from
the olfactory bulb via amygdala and limbic system is
changed. Possible consequences for our patients have
to remain speculative. Yet, two recent studies have
stressed a possible link between nutritional status and
stroke. Paquereau et al. [49] found malnutrition to be
associated with changed food intake and food prefer-
ences in 50 % of the stroke patients although their
study did not include olfactory assessment. Aliani et
al. [50] concluded that olfactory dysfunction in the
elderly and patients with dementia can lead to dietary
restrictions and thus negative implications on nutri-
tion and overall health.
The small number of patients in this study limits the
generalizability of our findings. Additionally, small cell
frequencies prevented us from analyzing relationships
between olfactory dysfunction and stroke classifications
(i.t. OCPS/TOAST) or other medical factors occurring in
patients. We included all available patients, and based on
MMSE score and NIHSS (baseline) it is assumed that the
patients included had rather mild to moderate impact of
the stroke. Thus, olfactory dysfunction may rather be
under-estimated in this sample since patients not return-
ing after one year may have even poorer functioning than
those included here. Lastly, we did not register drugs
patients were taking at the time of follow-up assessment,
although drug-induced olfactory (and even more taste)
dysfunction is well-known [21]. Yet, although drug-
induced olfactory dysfunction may be reversible, this may
not always be possible in these patients.
Conclusions
Results from the present study suggest that olfactory dis-
orders occur frequently even in mild to moderate
chronic stroke patients. The deficit seems to be related
to hyposmia and functional anosmia, and less to a
complete loss of smell. The findings strongly suggest the
inclusion of olfactory assessment in clinical routine. Fur-
thermore, there is urgent need to investigate long-term
impact on olfactory changes in stroke patients regarding
olfactory changes in VCI and dementia and the import-
ance of olfaction for flavor and quality of life in general.
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